Amyloid-β and tau pathologies relate to distinctive brain dysconnectomics in preclinical autosomal-dominant Alzheimer’s disease
Year: 2022
Type: article
Study design: Observational Study
Abstract: ABSTRACT The human brain is composed of functional networks that have a modular topology, where brain regions are organized into communities that form internally dense (segregated) and externally sparse (integrated) subnetworks that underlie higher-order cognitive functioning. It is hypothesized that amyloid-β and tau pathology in preclinical Alzheimer’s disease (AD) spread through functional networks, disrupting neural communication that results in cognitive dysfunction. We used high-resolution (voxel-level) graph-based network analyses to test whether in vivo amyloid-β and tau burden was associated with the segregation and integration of brain functional connections, and episodic memory, in cognitively-unimpaired Presenilin-1 E280A carriers who are expected to develop early-onset AD dementia in approximately 13 years on average. Compared to non-carriers, mutation carriers exhibited less functional segregation and integration in posterior default-mode network (DMN) regions, particularly the precuneus, and in the retrospenial cortex, which has been shown to link medial temporal regions and cortical regions of the DMN. Mutation carriers also showed greater functional segregation and integration in regions connected to the salience network, including the striatum and thalamus. Greater tau burden was associated with lower segregated and integrated functional connectivity of DMN regions, particularly the precuneus and medial prefrontal cortex. In turn, greater tau pathology was related to higher segregated and integrated functional connectivity in the retrospenial cortex, and the anterior cingulate cortex, a hub of the salience network. These findings enlighten our understanding of how AD-related pathology distinctly alters the brain’s functional architecture in the preclinical stage, possibly contributing to pathology propagation and ultimately resulting in dementia. SIGNIFICANCE STATEMENT Amyloid-β and tau pathologies in Alzheimer’s disease (AD) are hypothesized to propagate through functional networks. Research is needed to elucidate how AD-related pathologies alter the brain’s functional connections years before symptom-onset to help predict pathology accumulation and dementia risk. Using high-resolution (voxel-level) graph-based network analyses and PET imaging, we showed that greater tau burden was associated with largely dysconnectivity of posterior default-mode network brain regions, and increased connectivity of structures associated with the salience network and others that are critical for integrating information across neural systems in cognitively-unimpaired Presenilin-1 E280A carriers. Findings enlighten how amyloid-β and tau relate to distinct patterns of functional connectivity in regions that underlie memory functioning and are critical for information processing, helping predict disease progression.
Language: English
Subfield: Cognitive Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: hybrid
Funders: Alzheimer's Association, American Heart Association, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, Massachusetts General Hospital, Biogen, Departamento Administrativo de Ciencia, Tecnología e Innovación (COLCIENCIAS), Eisai, Universidad de Antioquia, National Institutes of Health, Genentech, Fonds de recherche du Québec – Nature et technologies, National Institute on Aging, National Heart, Lung, and Blood Institute
Awards: Sensory and Motor Streams in Preclinical and Clinical Stages of Alzheimer's Disease, G3339088943, G3569201499, Aerobic fitness as a modifier of neurodegeneration and cognitive decline in preclinical Alzheimer's disease, Working Memory in Preclinical Alzheimer's Disease: a Neuropsychological and Neuroimaging Investigation, Alzheimer's Disease Cooperative Study (ADCS), Genetic Profiles of the Spatiotemporal Causality of Tau and Amyloid in the Elderly Brain, Relationship between tau pathology and cognitive impairment in autosomal dominant Alzheimer's disease, Alzheimer's Disease Cooperative Study, Charting blood-biomarkers for cerebral small vessel diseases: insights from CADASIL, G8516574094, Training in Sleep, Circadian, and Respiratory Neurobiology, Massachusetts Alzheimer's Disease Research Center (MADRC)
OpenAlex ID: W4223982015
